Abstract:Atrial fibrillation is the most common sustained arrhythmia causing substantial morbidity and probably increasing the risk of death. Most commonly, it is divided into a paroxysmal form, when – by definition – episodes end spontaneously, or a persistent one that lasts and requires a medical or electrical intervention for its termination. It might be called permanent, when no further attempts seem to be indicated for its elimination. Until recently, therapeutic strategies aimed¶• at preventing cardiac embolism and¶• at restoring and maintaining sinus¶ rhythm by antiarrhythmic drugs.¶¶¶Long-term efficacy of the latter approach is poor, since less than 50% of patients can be maintained in stable sinus rhythm when periods of more than 1 year are considered.¶¶Can atrial fibrillation be cured?¶¶¶More than ten years ago Cox and coworkers demonstrated that the surgical compartimentation of both atria (MAZE procedure) is able to abolish atrial fibrillation in up to 90% of patients with chronic paroxysmal and also persistent atrial fibrillation. However, all studies trying to imitate the MAZE procedure by electrophysiological catheter-based techniques applying radiofrequency energy to produce transmural linear lesions were either not successful or showed a non-acceptable complication rate, especially a high rate of cerebrovascular accidents. The rationale behind the principle of compartimentation of the atria is the reduction of the critical atrial muscle mass neccessary to facilitate fibrillation of the atria. A different approach aiming especially at the problem of paroxysmal atial fibrillation is based on the observation that there might be a „focal trigger“ responsible for the initiation of the atrial tachyarrhythmia and that by eliminating this focal trigger atrial fibrillation can be avoided. This hypothesis was first verified in patients by Haïssaguerre et al., in fact experimental creation of „focal atrial fibrillation“ was presented by Moe and Abildskov more than 30 years ago. During the last 3 years the concept of curing paroxysmal atrial fibrillation by applying focal radiofrequency lesions was supported by the results of several groups in more than 200 patients: 60 to 85% of patients can be cured, but in almost half of the cases more than one procedure is neccessary. Most interestingly – and this is a finding of all investigators – more than 90% of the triggering ectopic foci are located in the pulmonary veins or in the pulmonary vein/left atrial junction. This concept is also supported by surgical experience from performing pulmonary vein isolations during open heart surgery.¶ Most recently, the concept of eliminating the trigger was extented and applied to patients with established persistent atrial fibrillation. Until now, it has not been well established how many patients with paroxysmal atrial fibrillation are „good candidates“ for a focal RF ablation procedure, nor is the risk of the procedure well defined. Besides the necessity of performing a transseptal catheterization there is the risk of cardiac embolism and pulmonary vein stenosis. The endpoint of the procedure is also not well defined: instead of trying to elimate the „trigger“ located in a pulmonary vein, it might be safer to isolate the „arrhythmogenic vein“. This however, is a difficult task with current catheter technologies. It can be expected that new catheter designs for mapping and ablation and – maybe – the use of alternative energy sources – e.g., ultrasound, microwave – will make the procedure easier and applicable to more patients with drug refractory atrial fibrillation.

Posttransplant atrial fibrillation: Evidence of early posttransplant recipient‐to‐donor atrioatrial connections

[Mechanism and re-ablation strategy for postablation atrial tachyarrhythmia in atrial fibrillation patients].

Current Understanding of Atrial Fibrillation Recurrence after Atrial Fibrillation Ablation: from Pulmonary Vein to Epicardium

National Incidence, Outcomes, and Management Strategies for Pre- and Post-Transplant Atrial Fibrillation in Heart Transplant Recipients

Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation

Early detection of pulmonary vein reconnection after isolation in patients with paroxysmal atrial fibrillation: a comparison of ATP-induction and reassessment at 30 minutes postisolation.

Management of Arrhythmias After Heart Transplant: Current State and Considerations for Future Research

What Is the Mechanism of the Atrial Arrhythmia in a Patient After Orthotopic Heart Transplantation?

Management of Atrial Arrhythmias After Lung Transplant

Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Atrioesophageal fistula post atrial fibrillation ablation: A multicenter study from China.

Cardiac resynchronization therapy with conduction system pacing in a long-term heart transplant recipient: A case report

Ablation of Atrial Tachycardia Originating from the Noncoronary Sinus: Case Report and Literature Review

Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy

Stiff left atrial syndrome with pulmonary veins occlusion after percutaneous radiofrequency ablation: a life-long complication that can lead to heart transplantation

Supraventricular bradycardia following heart transplantation necessitating pacemaker implantation – An analysis of possible underlying causes

Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?

Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy

Vorhofflimmern: Heilung durch fokale Hochfrequenz-Katheterablation?

Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation

Mid-to-long-term recurrence of atrial fibrillation in surgical treatment vs . catheter ablation: a meta-analysis using aggregated survival data